As of June 30, 2026, Natura Cosmeticos SA CEDEAR carries a market capitalization of 3.53T, placing it among publicly traded companies globally. Its enterprise value stands at 4.79T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.53T |
| Enterprise Value | 4.79T |
Natura Cosmeticos SA CEDEAR's next confirmed earnings release is scheduled for November 12, 2026.
| Earnings Date | 11/12/2026 |
As of June 30, 2026, Natura Cosmeticos SA CEDEAR has 1.37B shares outstanding.
| Shares Outstanding | 1.37B |
These figures are as of June 30, 2026. The price-to-sales ratio is 0.58, and the price-to-book ratio stands at 0.98.
| PS Ratio | 0.58 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 4.74 |
| P/FCF Ratio | -33.48 |
| P/OCF Ratio | -205.46 |
As of June 30, 2026, Natura Cosmeticos SA CEDEAR trades at an EV/EBITDA multiple of 8.91 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.78 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 17.59 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 4.79T versus a market cap of 3.53T, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.78 |
| EV / EBITDA | 8.91 |
| EV / EBIT | 17.59 |
As of June 30, 2026, Natura Cosmeticos SA CEDEAR maintains a current ratio of 1.68, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 53.70, indicating elevated leverage, while an interest coverage ratio of 1.85 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.68 |
| Quick Ratio | 0.35 |
| Debt / Equity | 53.70 |
| Debt / EBITDA | 3.60 |
| Interest Coverage | 1.85 |
Over the twelve months ended June 30, 2026, Natura Cosmeticos SA CEDEAR posted a negative return on equity (ROE) of -24.10, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -11.09, reflecting losses generated across the asset base. The company generates approximately 6.56B in revenue per employee across its workforce of 931.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.49 indicates how many times Natura Cosmeticos SA CEDEAR sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -24.10 |
| Return on Assets (ROA) | -11.09 |
| Revenue Per Employee | 6.56B |
| Employee Count | 931.75 |
| Inventory Turnover | 2.49 |
Over the twelve months ended June 30, 2026, Natura Cosmeticos SA CEDEAR recorded an income tax benefit of -26.24B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -124.50B and -762.44B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -26.24B |
As of the close on October 22, 2026, Natura Cosmeticos SA CEDEAR's stock has declined approximately 3.24% over the past 52 weeks. The 50-day moving average sits at 2,570.01, while the 200-day moving average is 2,634.07.
| 52-Week Price Change | -3.24% |
| 50-Day Moving Average | 2,570.01 |
| 200-Day Moving Average | 2,634.07 |
Over the twelve months ended June 30, 2026, Natura Cosmeticos SA CEDEAR generated 6.11T in revenue and converted that into -762.44B in net income, yielding earnings per share of -71.52. EBITDA reached 538.20B, while operating income came in at 308.91B.
| Revenue | 6.11T |
| Gross Profit | 4.02T |
| Operating Income | 308.91B |
| Pretax Income | -124.50B |
| Net Income | -762.44B |
| EBITDA | 538.20B |
| EBIT | 272.65B |
| Earnings Per Share (EPS) | -71.52 |
As of June 30, 2026, Natura Cosmeticos SA CEDEAR holds 676.82B in cash and equivalents against 1.94T in total debt, resulting in a net debt position of 1.43T. Total book value stands at 3.61T, with working capital of 1.32T providing operational flexibility.
| Cash & Cash Equivalents | 676.82B |
| Total Debt | 1.94T |
| Net Debt | 1.43T |
| Equity (Book Value) | 3.61T |
| Book Value Per Share | 2,628.40 |
| Working Capital | 1.32T |
Natura Cosmeticos SA CEDEAR produced -17.19B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -88.28B in capital expenditures, free cash flow totaled -105.47B - equivalent to -76.76 per share.
| Operating Cash Flow | -17.19B |
| Capital Expenditures | -88.28B |
| Free Cash Flow | -105.47B |
| FCF Per Share | -76.76 |
Over the twelve months ended June 30, 2026, Natura Cosmeticos SA CEDEAR posted a gross margin of 65.75, reflecting its pricing power and cost economics. The operating margin of 5.05 and net profit margin of -12.47 provide insight into operational efficiency.
| Gross Margin | 65.75 |
| Operating Margin | 5.05 |
| Pretax Margin | -2.04 |
| Profit Margin | -12.47 |
| EBITDA Margin | 8.80 |
Over the twelve months ended June 30, 2026, Natura Cosmeticos SA CEDEAR paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -2.99: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.28, meaning Natura Cosmeticos SA CEDEAR raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -0.28 |
| FCF Yield | -2.99 |
Already premium?